81 related articles for article (PubMed ID: 32413483)
1. Advanced glycation end products alter steroidogenic gene expression by granulosa cells: an effect partially reversible by vitamin D.
Merhi Z; Buyuk E; Cipolla MJ
Mol Hum Reprod; 2018 Jun; 24(6):318-326. PubMed ID: 29538679
[TBL] [Abstract][Full Text] [Related]
2. The role of sRAGE in cardiovascular diseases.
Delrue C; Delanghe JR; Speeckaert MM
Adv Clin Chem; 2023; 117():53-102. PubMed ID: 37973322
[TBL] [Abstract][Full Text] [Related]
3. Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies.
Hajizadeh-Sharafabad F; Shojaei-Zarghani S; Sharifi-Zahabi E; Gerami F; Pashaei MR
Glycoconj J; 2024 Feb; 41(1):35-46. PubMed ID: 38498243
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis.
Sellegounder D; Zafari P; Rajabinejad M; Taghadosi M; Kapahi P
Int Immunopharmacol; 2021 Sep; 98():107806. PubMed ID: 34352471
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products inhibit proliferation and primary cilia formation of myoblasts through receptor for advanced glycation end products pathway.
Suzuki S; Hayashi T; Egawa T
Biochem Biophys Res Commun; 2023 Dec; 684():149141. PubMed ID: 37897908
[TBL] [Abstract][Full Text] [Related]
6. Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease.
Ruiz HH; Ramasamy R; Schmidt AM
Endocrinology; 2020 Jan; 161(1):. PubMed ID: 31638645
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of vitamin D in AGE/RAGE-related cardiovascular diseases.
Lee TW; Kao YH; Chen YJ; Chao TF; Lee TI
Cell Mol Life Sci; 2019 Oct; 76(20):4103-4115. PubMed ID: 31250032
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
[TBL] [Abstract][Full Text] [Related]
9. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D: A Bridge between Kidney and Heart.
Secondulfo C; Visco V; Virtuoso N; Fortunato M; Migliarino S; Rispoli A; La Mura L; Stellato A; Caliendo G; Settembre E; Galluccio F; Hamzeh S; Bilancio G
Life (Basel); 2024 May; 14(5):. PubMed ID: 38792638
[TBL] [Abstract][Full Text] [Related]
11. Advanced Glycation End Products and Health: A Systematic Review.
Zhu J; Wang Z; Lv C; Li M; Wang K; Chen Z
Ann Biomed Eng; 2024 May; ():. PubMed ID: 38705931
[TBL] [Abstract][Full Text] [Related]
12. Advanced Glycation End-Products of Follicular Fluid are Associated with Embryo Morphokinetic Parameters and ART Outcomes.
Roushenas F; Izadi T; Jafarpour F; Hamdi K; Pashaiasl M; Fattahi A; Nasr-Esfahani MH
Reprod Sci; 2024 Apr; ():. PubMed ID: 38622476
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Metabolic Syndrome on Potential Aging Biomarkers in Participants with Metabolic Syndrome Compared to Healthy Controls.
Holmannova D; Borsky P; Andrys C; Kremlacek J; Fiala Z; Parova H; Rehacek V; Esterkova M; Poctova G; Maresova T; Borska L
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38275413
[TBL] [Abstract][Full Text] [Related]
14. Do advanced glycation end products contribute to food allergy?
Smith PK; Venter C; O'Mahony L; Canani RB; Lesslar OJL
Front Allergy; 2023; 4():1148181. PubMed ID: 37081999
[TBL] [Abstract][Full Text] [Related]
15. Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors.
Zheng W; Li H; Go Y; Chan XHF; Huang Q; Wu J
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364850
[TBL] [Abstract][Full Text] [Related]
16. The Perspective of Vitamin D on suPAR-Related AKI in COVID-19.
Liao TH; Wu HC; Liao MT; Hu WC; Tsai KW; Lin CC; Lu KC
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142634
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and Glomerulonephritis.
Gembillo G; Siligato R; Amatruda M; Conti G; Santoro D
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33671780
[TBL] [Abstract][Full Text] [Related]
18. The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease.
Bingül İ; Aydın AF; Küçükgergin C; Doğan-Ekici I; Doğru-Abbasoğlu S; Uysal M
Turk J Med Sci; 2021 Jun; 51(3):1500-1511. PubMed ID: 33421970
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and advanced glycation end products and their receptors.
Kheirouri S; Alizadeh M
Pharmacol Res; 2020 Aug; 158():104879. PubMed ID: 32413483
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
